VanEck Associates’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
VanEck Associates's ADPT Position: Q3 2026 in Review
VanEck Associates opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 8,886 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #1300 among its holdings. This is a return to the name: VanEck Associates previously reported a position in ADPT as recently as Q3 2023.
VanEck Associates first reported a position in ADPT in Q3 2022 and has held it in 6 quarters since. 332 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- VanEck Associates held 8,886 shares of Adaptive Biotechnologies worth $257K as of Q3 2026.
- Adaptive Biotechnologies was a new VanEck Associates position in Q3 2026.
- Adaptive Biotechnologies made up ﹤0.01% of VanEck Associates's portfolio in Q3 2026, its #1300 holding.
- VanEck Associates first reported a position in Adaptive Biotechnologies in Q3 2022 and has held it in 6 quarters since.
- 332 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on VanEck Associates's 13F filing for Q3 2026, filed 13 Nov 2026.